Dr. Blau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
NE Pacific St
# 1959
Seattle, WA 98195Phone+1 206-598-4100
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1992
Duke University HospitalResidency, Internal Medicine, 1986 - 1989
Ohio State University College of MedicineClass of 1986
Certifications & Licensure
WA State Medical License 1989 - 2026- American Board of Internal Medicine Internal Medicine
Clinical Trials
- A Crowd Sourcing Platform for Patients With Cancer Start of enrollment: 2018 Apr 26
- Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma Start of enrollment: 2023 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- 711 citationsA three-dimensional model of the yeast genomeZhijun Duan, Mirela Andronescu, Kevin Schutz, Sean J. McIlwain, Yoo Jung Kim
Nature. 2010-05-20 - 120 citationsComparison of 2 Commercially Available Next-Generation Sequencing Platforms in Oncology.Nicole M. Kuderer, Kimberly A. Burton, Sibel Blau, Andrea L. Rose, S Parker
JAMA Oncology. 2017-07-01 - 77 citationsMapping 3D genome architecture through in situ DNase Hi-CVijay Ramani, Darren A. Cusanovich, Ronald J. Hause, Wenxiu Ma, Ruolan Qiu
Nature Protocols. 2016-11-01
Grant Support
- Modeling Mammalian GenomesNational Institute Of General Medical Sciences2011–2012
- Erythropoietin Blockade For The Treatment Of CancerNational Cancer Institute2008–2011
- Self Renewal And Differentiation Of Embryonic Stem CellsNational Institute Of General Medical Sciences2007–2011
- Regulation Of Human Embryonic Stem Cell Self-RenewalNational Institute Of General Medical Sciences2007–2011
- Cell Biosystems Firefly 3000 SystemNational Center For Research Resources2010
- Receptor Specifcity In The Proliferation And Differentiation Of Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2009
- Receptor Specificity In The Proliferation And Differentiation Of Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2008
- Safety Of Chemical Inducers Of Dimmerization And Expanding GM Erythroid CellsNational Heart, Lung, And Blood Institute2004–2008
- Administrative CoreNational Institute Of General Medical Sciences2007
- Uw/Fhcrc Exploratory Center For Human ES Cell ResearchNational Institute Of General Medical Sciences2003–2006
- Hemopoietic Stem Cell PlasticityNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- Proliferative Switch For Genetically Modified CellsNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2004
- Proliferation % Differentiation Of Hemopoietic Stem CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2002
- Core--ClinicalNational Heart, Lung, And Blood Institute2000–2002
- Mixed Chimerism In The HemoglobinopathiesNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- Stem Cell Expansion Using Chemical Inducers Of Dimerization (CID)National Heart, Lung, And Blood Institute1999–2002
- Effects Of Hydroxyurea In Sickle Cell DiseaseNational Center For Research Resources2000
- Effects Of Hydroxyurea On Circulating Progenitors In Sickle Cell DiseaseNational Center For Research Resources1998–2000
- Butyrate Response Elements Within The Beta-Globin LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1994
- Butyrate Response Elements Within The Beta Globin LocusNational Institute Of Diabetes And Digestive And Kidney Diseases1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
